Furthermore, higher TRIB3 and ULK1 expression is associated with a poor prognosis in breast cancer [44] while higher LAMP3 expression has been associated with lymph node positivity and hormone receptor negative breast cancers [45,46,47]. Here, LAMP3 is linked to breast cancer.